These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11696976)

  • 1. Genomic organisation of the mouse Ret proto-oncogene.
    Panetta D; Yin L; Barale R; Romeo G; Ravazzolo R; Ceccherini I; Puliti A
    DNA Seq; 2001; 11(6):501-6. PubMed ID: 11696976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA sequence and genomic structure of the rat RET proto-oncogene.
    Matera I; De Miguel-Rodríguez M; Fernández-Santos JM; Santamaria G; Puliti A; Ravazzolo R; Romeo G; Galera-Davidson H; Ceccherini I
    DNA Seq; 2000; 11(5):405-17. PubMed ID: 11328649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physical map of the human RET proto-oncogene.
    Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
    Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exon structure and flanking intronic sequences of the human RET proto-oncogene.
    Ceccherini I; Bocciardi R; Luo Y; Pasini B; Hofstra R; Takahashi M; Romeo G
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1288-95. PubMed ID: 7902707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the human ret proto-oncogene using exon trapping.
    Kwok JB; Gardner E; Warner JP; Ponder BA; Mulligan LM
    Oncogene; 1993 Sep; 8(9):2575-82. PubMed ID: 8361767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.
    Munnes M; Patrone G; Schmitz B; Romeo G; Doerfler W
    Oncogene; 1998 Nov; 17(20):2573-83. PubMed ID: 9840920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
    Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
    Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.
    Romeo G; Ronchetto P; Luo Y; Barone V; Seri M; Ceccherini I; Pasini B; Bocciardi R; Lerone M; Kääriäinen H
    Nature; 1994 Jan; 367(6461):377-8. PubMed ID: 8114938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse ret finger protein (rfp) proto-oncogene is expressed at specific stages of mouse spermatogenesis.
    Cao T; Shannon M; Handel MA; Etkin LD
    Dev Genet; 1996; 19(4):309-20. PubMed ID: 9023983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human GFRA1: cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility.
    Angrist M; Jing S; Bolk S; Bentley K; Nallasamy S; Halushka M; Fox GM; Chakravarti A
    Genomics; 1998 Mar; 48(3):354-62. PubMed ID: 9545641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
    Marsh DJ; Learoyd DL; Andrew SD; Krishnan L; Pojer R; Richardson AL; Delbridge L; Eng C; Robinson BG
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.
    Lorenzo MJ; Eng C; Mulligan LM; Stonehouse TJ; Healey CS; Ponder BA; Smith DP
    Oncogene; 1995 Apr; 10(7):1377-83. PubMed ID: 7731689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene.
    Ceccherini I; Hofstra RM; Luo Y; Stulp RP; Barone V; Stelwagen T; Bocciardi R; Nijveen H; Bolino A; Seri M
    Oncogene; 1994 Oct; 9(10):3025-9. PubMed ID: 8084609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
    Donis-Keller H; Dou S; Chi D; Carlson KM; Toshima K; Lairmore TC; Howe JR; Moley JF; Goodfellow P; Wells SA
    Hum Mol Genet; 1993 Jul; 2(7):851-6. PubMed ID: 8103403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.
    Padberg BC; Schröder S; Jochum W; Kastendieck H; Roth J; Heitz PU; Komminoth P
    Am J Pathol; 1995 Dec; 147(6):1600-7. PubMed ID: 7495285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.
    Iwamoto T; Taniguchi M; Asai N; Ohkusu K; Nakashima I; Takahashi M
    Oncogene; 1993 Apr; 8(4):1087-91. PubMed ID: 8455936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
    Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
    Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.